TPCW
MLAB icon

TD Private Client Wealth’s Mesa Laboratories MLAB Stock Holding History

TD Private Client Wealth’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2
Closed -$282 – 1245
2022
Q3 		$282 Hold
2
– – ﹤0.01% 1202
2022
Q2 		$408 Hold
2
– – ﹤0.01% 1205
2022
Q1 		$510 Hold
2
– – ﹤0.01% 1238
2021
Q4 		$656 Hold
2
– – ﹤0.01% 1102
2021
Q3 		$605 Buy
+2
New +$568 ﹤0.01% 1150

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

TD Private Client Wealth's MLAB Position: Q4 2022 in Review

TD Private Client Wealth sold out of Mesa Laboratories (MLAB) in Q4 2022, closing a stake of 2 shares — an estimated $282 sold.

TD Private Client Wealth first reported a position in MLAB in Q3 2021 and held it in 5 quarters. The position peaked at $656 in Q4 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q4 2022.

  • TD Private Client Wealth reported no remaining Mesa Laboratories position as of Q4 2022 after selling out during the quarter.
  • TD Private Client Wealth sold 2 Mesa Laboratories shares in Q4 2022, an estimated $282.
  • TD Private Client Wealth first reported a position in Mesa Laboratories in Q3 2021 and held it in 5 quarters.
  • TD Private Client Wealth's Mesa Laboratories position peaked at $656 in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q4 2022.

Based on TD Private Client Wealth's 13F filing for Q4 2022, filed 16 Aug 2024.